On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic
1 year ago
On Tuesday, Novavax (NASDAQ: NVAX) cut its annual revenue forecast, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
The U.S. Food and Drug Administration has put on hold a trial of Novavax’s (NASDAQ: NVAX) COVID-influenza and its standalone
The European Commission authorized Novavax’s (NASDAQ: NVAX) updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the
On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX)
On Thursday, Novavax (NASDAQ: NVAX) trimmed its annual revenue forecast again and said it would pare back its presence in
Novavax (NASDAQ: NVAX) stock climbed almost 50% in intraday trading Monday after TD Cowen analyst raised its price target. Brendan
2 years ago
Novavax (NASDAQ: NVAX) stock soared almost 100% in intraday trading after signing a COVID-19 license deal with Sanofi and withdrawing
Shares of Novavax, Inc. (NASDAQ: NVAX) surged 28.15% on Monday following two major announcements: the revised agreement with the Government
